Dr. Evgenii Shumilov – Oncology and Hematology – Outstanding Scientist Award

Posted on by sciencefather

Dr. Evgenii Shumilov - Oncology and Hematology - Outstanding Scientist Award

University Hospital Münster Medical Clinic A -  Germany

Author Profile 

ORCID 

🎓 Early academic pursuits

Dr. Evgenii Shumilov began his academic journey in kirovskaya gebiet, russland, where he completed his general secondary education in june 2006. driven by a passion for human biology and clinical care, he enrolled in the staatliche medizinische akademie in kirow in 2006. the following year, he transitioned to the esteemed st. petersburger staatliche medizinische universität i.p. pawlow, where he pursued his degree in human medicine until 2012. during this formative period, he developed a growing interest in the biochemical pathways influencing addiction, which would later shape his doctoral research.

🏥 Professional endeavors

His professional career started immediately after his graduation with a clinical internship in internal medicine at the universitätsklinikum st. petersburg i.p. pawlow. dr. shumilov then completed a specialized clinical training in oncology at the renowned n.n. petrow institute for oncology. from 2015 to 2021, he continued his facharztausbildung (specialist training) in internal medicine, hematology, and oncology at the universitätsmedizin göttingen. since 2021, he has served in various capacities at the universitätsklinikum münster, advancing to oberarzt (senior physician) in the day clinic of oncology by 2022. his role requires the coordination of clinical therapies, implementation of modern diagnostics, and integration of interdisciplinary care — akin to the precision and optimization seen in power electronics systems.

🔬 Contributions and research focus

Dr. Shumilov has made significant scientific contributions in the field of pharmacology and hemato-oncology. between 2012 and 2015, he pursued a doctoral program in pharmacology at the anichkow institute for experimental medicine, focusing on neuropharmacology and the role of orexin-1 receptors in addiction — a study that mirrors the regulatory mechanisms of feedback and control in power electronics. in 2018, he earned a second doctorate (dr. med.) from the university of bern, switzerland, with a dissertation exploring genetic mutations bridging Oncology and Hematology hematopoietic lineages and solid tumors in the age of high-throughput sequencing. his work has helped redefine diagnostic paradigms in clinical oncology.

🌍 Impact and influence

Dr. Shumilov’s cross-disciplinary expertise bridges clinical practice and molecular diagnostics. his innovative thinking, reflected in his dual doctoral research and international academic Oncology and Hematology exposure, positions him as a leader in precision medicine. like the transformative role of power electronics in renewable energy systems, his influence lies in optimizing diagnostic accuracy and tailoring therapies for oncology patients. he is actively mentoring junior clinicians, integrating translational research into routine care, and contributing to academic networks across europe and russia.

📚 Academic citations and recognitions

He has received notable academic recognition, including a posterpreis at the dgho annual meeting in stuttgart (2017), and the prestigious dfg “clinician scientist” funding from 2020 to 2021. his scientific contributions are frequently cited in studies on neuropharmacology and next-generation sequencing diagnostics. his work on orexin receptors and hematologic malignancies Oncology and Hematology continues to influence both pharmacologic models and clinical protocols.

🌱 Legacy and future contributions

Dr. Shumilov’s legacy lies in his capacity to interweave basic science with clinical oncology. he is currently leading projects that integrate high-throughput genomic data with patient-specific therapy plans, aiming for breakthroughs in hematologic and solid tumor treatments. with a forward-looking perspective, he is exploring digital integration and ai-assisted diagnostics, similar to how power electronics revolutionize control in automated systems. his future vision includes strengthening international research collaborations and expanding educational programs for medical scientists.

Notable Publications 

  • Title: Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma
    Author(s): Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib, Paolo Mazzeo, Rebecca Wurm-Kuczera, Vladan Vucinic, Udo Holtick, Hristo Boyadzhiev, Thomas Melchardt, Alexander Sebastian Hölscher, et al.
    Journal: Blood Advances

  • Title: Allogeneic stem cell transplantation against aggressive lymphomas: graft-versus-lymphoma effects in peripheral T-cell lymphoma and diffuse large B-cell lymphoma after myeloablative conditioning
    Author(s): Evgenii Shumilov, Lena Levien, Paolo Mazzeo, Wolfram Jung, Andreas Leha, Raphael Koch, Justin Hasenkamp, Gerald Wulf
    Journal: Leukemia & Lymphoma

  • Title: Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study
    Author(s): Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff, Meng Wang, Thomas Melchardt, Udo Holtick, Ulrike Bacher, Philipp B. Staber, Paolo Mazzeo, Corinna Leng, et al.
    Journal: Blood Advances

  • Title: Benefit of repeated COVID‐19 vaccination for patients with B‐cell malignancies
    Author(s): Ulrike Bacher, Evgenii Shumilov, Thomas Pabst
    Journal: British Journal of Haematology

  • Title: Radiotherapy in Combination with Systemic Therapy for Multiple Myeloma—A Critical Toxicity Evaluation in the Modern Treatment Era
    Author(s): Michael Oertel, Tom Schlusemann, Evgenii Shumilov, Gabriele Reinartz, Anne Bremer, Stephan Rehn, Georg Lenz, Cyrus Khandanpour, Hans Theodor Eich
    Journal: Cancers

Ms. Chanchal Choudhary – Molecular and Developmental Biology – Best Researcher Award

Posted on by sciencefather

Ms. Chanchal Choudhary - Molecular and Developmental Biology - Best Researcher Award

Jawaharlal Nehru University - India 

Author Profile 

ORCID 

🎓 Early academic pursuits

Chanchal Choudhary’s academic journey began with a deep interest in molecular and developmental biology. She pursued a Doctor of Philosophy (PhD) in Life Sciences at Jawaharlal Nehru University, New Delhi. Her coursework, completed with an impressive CGPA of 8.06, laid a strong foundation in the intricacies of developmental biology. Her PhD research, titled "Understanding the role of TCTP2 in Dictyostelium discoideum," delved into the molecular dynamics of Translationally Controlled Tumor Protein (TCTP) and its critical role in various cellular processes.

🏢 Professional endeavors

Chanchal has amassed extensive experience in independent research and has been at the forefront of high-impact studies. Her work has led to several peer-reviewed publications and presentations at international conferences. This trajectory has not only honed her expertise but also positioned her as a leader in cross-functional projects. She has demonstrated a strong capability to mentor emerging scientists, fostering an environment of growth and innovation within her research teams.

🔬 Contributions and research focus

The cornerstone of Chanchal’s research lies in her in-depth exploration of TCTP2 in Dictyostelium discoideum. Her findings reveal the protein’s pivotal role in autophagy regulation, which is Molecular and Developmental Biology crucial for understanding cell proliferation, survival, and death. By elucidating the functions of TPT2, her research offers valuable insights into cellular dynamics and developmental biology. This study not only advances basic biological knowledge but also underscores the therapeutic potential of targeting TCTP in cancer treatment.

🌟 Accolades and recognition

Chanchal’s scholarly contributions have earned her recognition in the scientific community. Her research findings, published in esteemed journals, reflect her dedication and innovative Molecular and Developmental Biology approach. She has presented her work at prestigious international conferences, where she has been commended for her clarity and depth of knowledge. These accolades highlight her commitment to advancing the field of molecular and developmental biology.

🌍 Impact and influence

Chanchal’s work has significantly impacted the understanding of cellular processes in both basic and applied sciences. Her research on TCTP2 in Dictyostelium discoideum provides a Molecular and Developmental Biology framework for further studies on cell proliferation and autophagy. This has far-reaching implications for cancer research, potentially paving the way for novel therapeutic strategies. Her mentorship and collaborative projects have also influenced the next generation of scientists, fostering a culture of inquiry and discovery.

📚 Legacy and future contributions

Chanchal Choudhary’s legacy is rooted in her groundbreaking research and her dedication to the scientific community. As she continues her career, her future contributions are anticipated to further unravel the complexities of molecular biology and its applications in health and disease. Her ongoing commitment to addressing biological challenges through innovative research promises to leave a lasting impact on the field.

Notable Publications 

  • Title: Analyzing the functions of Translationally controlled tumor protein2 during growth, development and autophagy of Dictyostelium discoideum
    Authors: Chanchal Choudhary, Bhavya Jain, Shweta Saran
    Journal: Experimental Cell Research
    DOI: 10.1016/j.yexcr.2024.114400
    ISSN: 0014-4827
    Publication Date: January 2025
  • Title: In silico analysis of Translationally-Controlled Tumour Proteins of social amoeba Dictyostelium discoideum
    Authors: Chanchal Choudhary, Shweta Saran
    Journal: Biospectra
    DOI: 10.5281/ZENODO.14062730
    Publication Date: January 15, 2024

Dr. Vikas Shukla – Nanomedicine and Immunology – Best Researcher Award

Posted on by sciencefather

Dr. Vikas Shukla - Nanomedicine and Immunology - Best Researcher Award

AIIMS, New Delhi - India 

Author Profile

GOOGLE SCHOLAR 

Early academic pursuits 📚

Vikas Shukla's academic journey began with a deep-rooted passion for nanobiotechnology and immunology. He dedicated himself to gaining a solid foundation in the life sciences, eventually leading him to pursue advanced studies in these cutting-edge fields. His education, characterized by rigorous training, provided the tools necessary for his future contributions to scientific research. Over the years, vikas built an impressive knowledge base in bacterial culture, cell culture, and immunoassays, which would serve as the backbone of his research career.

Professional endeavors 🏢

currently serving as a research scientist-II at the all india institute of medical sciences (aiims) in new delhi, india, vikas brings over 8 years of extensive experience to the forefront. His role at aiims, within the department of plastic, reconstructive & burns surgery, involves not only laboratory-based research but also project management. This balance between hands-on science and overseeing project timelines ensures that he contributes effectively to the scientific and clinical goals of his department.

Contributions and research focus 🔬

Vikas's research primarily revolves around nanobiotechnology and immunology, with a keen focus on innovative solutions in medical science. He has demonstrated exceptional expertise in bacterial culture, cell culture, immunoassays, and small animal handling. His work seeks to bridge the gap between complex scientific Nanomedicine and Immunology theories and their real-world applications, particularly in healthcare. Vikas’s research outputs have helped advance understanding in both fundamental immunological responses and the application of nanotechnology in therapeutic treatments.

Accolades and recognition 🏅

throughout his career, vikas has received commendations for his meticulous work and contributions to the field. His ability to keep projects both on time and on Nanomedicine and Immunology budget while maintaining high scientific standards has not gone unnoticed. He is widely recognized among his peers and colleagues for his diligence, precision, and ability to translate complex scientific concepts into more accessible knowledge. His exceptional communication skills have further bolstered his reputation as a skilled researcher and project manager.

Impact and influence 🌍

Vikas’s research holds significant implications for the fields of immunology and nanobiotechnology, particularly within clinical settings. His work on developing innovative medical treatments and enhancing immunological responses has the potential to save lives and improve patient outcomes. His influence extends beyond the laboratory, as his project management skills ensure that critical research is completed efficiently, benefiting both the scientific community and society as a whole.

Legacy and future contributions 🔮

looking ahead, Vikas Shukla’s legacy will likely be defined by his contributions to advancing the use of nanotechnology in medicine. His ongoing work at aiims and within the broader scientific community will continue to impact the development of new therapeutic approaches and enhance our understanding of immune Nanomedicine and Immunology responses. His commitment to pushing the boundaries of science while managing complex projects ensures that his influence will be felt for years to come.

Notable Publications 

Smart Drug-Delivery Systems in the Treatment of Rheumatoid Arthritis: Current, Future Perspectives  2021

Dynamic light scattering (DLS) particle size analysis for biomedical nanotechnology  2023

Downmodulation of lysophosphatidic acid by Berberine loaded folate-conjugated glycol chitosan nanoparticles  2022

Therapeutic use of mesenchymal stem cells against SARS-Cov-2: present and future prospects  2022

Phytomedicine Meets Nanotechnology: A Cellular Approach to Rheumatoid Arthritis Treatment 2024